首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Joint bone spine

缩写:JOINT BONE SPINE

ISSN:1297-319X

e-ISSN:1778-7254

IF/分区:5.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3458条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Fabiola Atzeni,Katie Bechman,Angelo Tropea et al. Fabiola Atzeni et al.
Objective: Cardiovascular disease contributes to morbidity and mortality in rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Systemic inflammation drives risk in RA, while PsA may involve additional immune-metabol...
Thibault Orvain,Maxime Samson,Anael Dumont et al. Thibault Orvain et al.
Objectives: To evaluate the proportion of patients with giant cell arteritis (GCA)-related large-vessel involvement (LVI) with a complete metabolic remission on PET/CT after treatment with glucocorticoids (GC) only. ...
Kimberley Dolium,Ramez Mebrouk,Marie Binvignat et al. Kimberley Dolium et al.
Objective: Atopy has been identified as a risk factor for osteoarthritis, but without specifying its impact on disease severity. We sought to investigate the association between atopy and the symptomatic and structural se...
Yanxia Gan,Xi Yu,Puhui Zhou Yanxia Gan
Exposure to heavy metals is regarded as a potential contributor to the development of hyperuricemia (HU). However, related research findings are inconsistent. This systematic review and meta-analysis aimed to explore the association between...
Annik Steimer,Jonas Brändli,Andrea Götschi et al. Annik Steimer et al.
Objectives: In patients with psoriatic arthritis, articular responses vary by joint location with both tumour necrosis factor inhibitors (TNFi). It remains unknown whether this also applies to patients with axial spondylo...
Diego Benavent,Victoria Navarro-Compán,Dafne Capelusnik et al. Diego Benavent et al.
Objectives: To assess whether symptom duration modifies flare risk after biologic/targeted synthetic DMARD (b/ts DMARDs) withdrawal in axial spondyloarthritis (axSpA) following remission/inactive disease. ...